|
|
|
The iGuard.org Business Model
iGuard.org.org was created by professionals with decades of experience in healthcare
market research, clinical drug development, and drug safety. Initially funded by Quintiles Transnational, the
leading provider of clinical research services, the purpose of iGuard.org is to promote better communication
and research about drug safety.
We believe that the patient can play an important role in improving drug safety. Today, public and private
organizations spend millions of dollars on drug safety research and risk management programs - often with
disappointing results. At iGuard.org, we feel strongly that connecting patients and researchers will allow us to
do better, faster and more cost-effective research.
To cover the cost of operating our efficiently structured service, iGuard.org will soon begin to offer
customized drug safety studies, risk management programs, and other research programs. We are confident that
these research opportunities will cover the cost of our communication network and help improve the safety of
medicines.
Register today to get personalized safety information and begin sharing feedback about your medications.
|
